These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 33471966)

  • 1. A clinical score for predicting left ventricular reverse remodelling in patients with dilated cardiomyopathy.
    Kimura Y; Okumura T; Morimoto R; Kazama S; Shibata N; Oishi H; Araki T; Mizutani T; Kuwayama T; Hiraiwa H; Kondo T; Murohara T
    ESC Heart Fail; 2021 Apr; 8(2):1359-1368. PubMed ID: 33471966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Phenotype and Genotype Associations With Improvement in Left Ventricular Function in Dilated Cardiomyopathy.
    Verdonschot JAJ; Hazebroek MR; Wang P; Sanders-van Wijk S; Merken JJ; Adriaansen YA; van den Wijngaard A; Krapels IPC; Brunner-La Rocca HP; Brunner HG; Heymans SRB
    Circ Heart Fail; 2018 Nov; 11(11):e005220. PubMed ID: 30571196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel predictors of left ventricular reverse remodeling in individuals with recent-onset dilated cardiomyopathy.
    Kubanek M; Sramko M; Maluskova J; Kautznerova D; Weichet J; Lupinek P; Vrbska J; Malek I; Kautzner J
    J Am Coll Cardiol; 2013 Jan; 61(1):54-63. PubMed ID: 23287372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relations between circulating and myocardial fibrosis-linked microRNAs with left ventricular reverse remodeling in dilated cardiomyopathy.
    Dziewięcka E; Totoń-Żurańska J; Wołkow P; Kołton-Wróż M; Pitera E; Wiśniowska-Śmiałek S; Khachatryan L; Karabinowska A; Szymonowicz M; Podolec P; Rubiś P
    Adv Clin Exp Med; 2020 Mar; 29(3):285-293. PubMed ID: 32207584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Predictive factors of left ventricular reverse remodeling in patients with idiopathic or secondary dilated cardiomyopathy].
    Cai H; Fang Z; Weng Z; Jin X
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Jan; 38(1):81-88. PubMed ID: 33177028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial Tissue Reverse Remodeling After Guideline-Directed Medical Therapy in Idiopathic Dilated Cardiomyopathy.
    Xu Y; Li W; Wan K; Liang Y; Jiang X; Wang J; Mui D; Li Y; Tang S; Guo J; Guo X; Liu X; Sun J; Zhang Q; Han Y; Chen Y
    Circ Heart Fail; 2021 Jan; 14(1):e007944. PubMed ID: 33185117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential predictive value of cardiac mechanics for left ventricular reverse remodelling in dilated cardiomyopathy.
    Kan A; Fang Q; Li S; Liu W; Tao X; Huang K; Hu M; Feng Z; Gong L
    ESC Heart Fail; 2023 Dec; 10(6):3340-3351. PubMed ID: 37697922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of endomyocardial biopsy in conjunction with cardiac magnetic resonance imaging to predict left ventricular reverse remodeling in idiopathic dilated cardiomyopathy.
    Ishii S; Inomata T; Fujita T; Iida Y; Ikeda Y; Nabeta T; Yanagisawa T; Naruke T; Mizutani T; Koitabashi T; Takeuchi I; Ako J
    Heart Vessels; 2016 Dec; 31(12):1960-1968. PubMed ID: 26920939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and prognosis implications of long term left ventricular reverse remodeling in patients with dilated cardiomyopathy.
    Ruiz-Zamora I; Rodriguez-Capitan J; Guerrero-Molina A; Morcillo-Hidalgo L; Rodriguez-Bailon I; Gomez-Doblas JJ; de Teresa-Galvan E; Garcia-Pinilla JM
    Int J Cardiol; 2016 Jan; 203():1114-21. PubMed ID: 26651150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcomes and reverse remodelling in recently diagnosed unexplained left ventricular systolic dysfunction.
    Kuchynka P; Podzimkova J; Marek J; Danek BA; Vitkova I; Kreidlova M; Roblova L; Kovarnik T; Simek S; Horak J; Habasko J; Linhart A; Palecek T
    ESC Heart Fail; 2024 Apr; 11(2):859-870. PubMed ID: 38204216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between mutation status and left ventricular reverse remodelling in dilated cardiomyopathy.
    Dal Ferro M; Stolfo D; Altinier A; Gigli M; Perrieri M; Ramani F; Barbati G; Pivetta A; Brun F; Monserrat L; Giacca M; Mestroni L; Merlo M; Sinagra G
    Heart; 2017 Nov; 103(21):1704-1710. PubMed ID: 28416588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Effect of Pulmonary Artery Diameter/Ascending Aorta Diameter Ratio on Left Ventricular Reverse Remodeling in Patients With Dilated Cardiomyopathy.
    Shibata N; Hiraiwa H; Kazama S; Kimura Y; Araki T; Mizutani T; Oishi H; Kuwayama T; Kondo T; Morimoto R; Okumura T; Murohara T
    Circ J; 2022 Jun; 86(7):1102-1112. PubMed ID: 35082187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The predictive value of coronary microvascular dysfunction for left ventricular reverse remodelling in dilated cardiomyopathy.
    Kan A; Leng Y; Li S; Lin F; Fang Q; Tao X; Hu M; Gong L
    Front Cardiovasc Med; 2023; 10():1301509. PubMed ID: 38111885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time course of left ventricular reverse remodeling in response to pharmacotherapy: clinical implication for heart failure prognosis in patients with idiopathic dilated cardiomyopathy.
    Ikeda Y; Inomata T; Iida Y; Iwamoto-Ishida M; Nabeta T; Ishii S; Sato T; Yanagisawa T; Mizutani T; Naruke T; Koitabashi T; Takeuchi I; Nishii M; Ako J
    Heart Vessels; 2016 Apr; 31(4):545-54. PubMed ID: 25686768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Native T1 heterogeneity for predicting reverse remodeling in patients with non-ischemic dilated cardiomyopathy.
    Kinoshita M; Kato S; Kodama S; Azuma M; Nakayama N; Fukui K; Saito N; Iwasawa T; Kimura K; Tamura K; Utsunomiya D
    Heart Vessels; 2022 Sep; 37(9):1541-1550. PubMed ID: 35320392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporal change of myocardial tissue character is associated with left ventricular reverse remodeling in patients with dilated cardiomyopathy: A cardiovascular magnetic resonance study.
    Nabeta T; Inomata T; Fujita T; Iida Y; Ikeda Y; Sato T; Ishii S; Maekawa E; Mizutani T; Naruke T; Koitabashi T; Inoue Y; Ako J
    J Cardiol; 2017 Aug; 70(2):185-191. PubMed ID: 27979675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late gadolinium enhancement for re-worsening left ventricular ejection fraction in patients with dilated cardiomyopathy.
    Nabeta T; Ishii S; Ikeda Y; Maemura K; Oki T; Yazaki M; Fujita T; Naruke T; Inomata T; Ako J
    ESC Heart Fail; 2021 Feb; 8(1):615-624. PubMed ID: 33270357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevalence and predictors of left ventricular reverse remodeling in patients with recent onset dilated cardiomyopathy on tailored medical therapy].
    Zhang J; Zou CH; Huang Y; Zhou Q; Zhang YH; Lyu R
    Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Apr; 44(4):315-20. PubMed ID: 27112609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [T1 mapping and late gadolinium enhancement for the diagnosis of dilated cardiomyopathy].
    Cui Q; Yu J; Ge X; Gao G; Liu Y; Shen W
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Dec; 32(12):1506-1510. PubMed ID: 33541506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of Addition of Magnetic Resonance Imaging to Echocardiographic Imaging to Predict Left Ventricular Reverse Remodeling in Patients With Nonischemic Cardiomyopathy.
    Merlo M; Masè M; Vitrella G; Belgrano M; Faganello G; Di Giusto F; Boscutti A; Gobbo M; Gigli M; Altinier A; Lesizza P; Barbati G; Ramani F; De Luca A; Morea G; Cova MA; Stolfo D; Sinagra G
    Am J Cardiol; 2018 Aug; 122(3):490-497. PubMed ID: 29958711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.